Drug Research
Sygnature Discovery successfully identifies potent SHP2 degrader compounds in...
Sygnature Discovery and UBE Corporation have begun a collaboration on a Hit-to-Lead program to identify SHP2 degraders.Â
SHP2 is a tyrosine-specific phosphatase implicated in human cancers...
Drug Research
Growing Demand Reshaping The Future of Aseptic Fill Finish
It's important to highlight that aseptic fill finish operations demand skilled personnel, specialized automated equipment, a controlled cleanroom environment, and constant supervision to maintain the...
BioPharma
Biotech Innovations In The Face of Economic Uncertainty
While the pharmaceutical industry has traditionally been seen as recession-proof, with a constant demand for medicines and new treatment options, it currently faces significant challenges....
Drug Research
Sever Pharma Solutions breaks ground with new high potency...
Sever Pharma Solutions, a leading pharmaceutical contract development and manufacturing organization (CDMO), has announced the groundbreaking of its new high potency active pharmaceutical ingredients (HPAPI)...
Drug Research
Bora merges with Sunway Biotech to launch global Nutraceuticals...
Bora Health, a global design, development and distribution partner of pharmaceuticals and health foods and part of the Bora group, has announced its merged with...
Drug Research
Accelerating Drug Development Through CDMO Partnerships
Based on current market analyses, global pharmaceutical spending is projected to reach approximately $1,742 billion by 2025. Concurrently, spending on COVID-19 vaccines and therapeutics is...
Drug Research
Samsung Biologics announces expanded strategic agreement with Bristol Myers...
Samsung Biologics announced a new agreement with Bristol Myers Squibb for large-scale manufacturing of a Bristol Myers Squibb commercial antibody cancer drug substance.
Bristol Myers Squibb...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.